9.12.2012
1:00 pm - 2:00 pm EST
Webinar
After years of uncertainty over the future of the federal government’s Small Business Innovation Research (SBIR) program, the FY12 National Defense Authorization Act (NDAA) has finally reauthorized the SBIR program for six years. As part of this reauthorization, the NDAA also authorized changes to SBIR rules to allow small firms that are majority-owned by venture capital operating companies, hedge funds, or private equity firms to receive SBIR grants. Regulatory conditions imposed upon such investors will affect the structure of investments in SBIR funded companies. This webinar will focus on what changes are likely to be adopted in the SBIR program, and how investments in or acquisitions of SBIR funded companies may be affected by regulations being finalized at the U.S. Small Business Administration (SBA). Our panel of top legal, legislative, and industry professionals will offer practical advice and address such questions as:
Panelists - Jonathan Cain, Member, Mintz Levin - Alexander Hecht, Vice President of Government Relations, ML Strategies - Cartier Esham, Senior Director Emerging Company Health and Regulatory Affairs, Biotechnology Industry Organization - Kelly Slone, Vice President of Federal Life Science Policy, National Venture Capital Association
Event Details Structuring Investment in SBIR Funded Companies: New Opportunities for Venture Capital
Your privacy is important to us. Mintz Levin uses the names, e-mail addresses, and notes you provide only to transmit the information you would like to send to us through this page. We do not sell the information collected through this website to anyone. If you are not a current Mintz Levin client, please do not include any information that you or another party considers confidential on this form. Please also see our Disclaimer & Privacy Statement.